We are creating some awesome events for you. Kindly bear with us.

Singapore to Boost Biologics and Vaccine Manufacturing

To improve Singapore’s biologics manufacturing capabilities, top pharmaceutical companies will collaborate with research groups from the Agency for Science, Technology and Research (A*STAR), Singapore Institute of Technology (SIT), National University of Singapore (NUS), Nanyang Technological University, Singapore (NTU Singapore) and its innovation and enterprise company, NTUitive.

Through the Biologics Pharma Innovation Programme Singapore (BioPIPS), a consortium founded by A*STAR with assistance from the Singapore Economic Development Board (EDB), their relationship will be formally established.

BioPIPS aims to expand Singapore’s biologics production capabilities, including those for vaccines and recombinant therapeutic proteins. Biologics and vaccinations were crucial in averting severe sickness and saving lives worldwide during the COVID-19 pandemic.

Leading industry professionals and Singapore’s research ecosystem will join forces through the consortium to increase manufacturing productivity, boost operational effectiveness, and meet sustainability objectives. The consortium’s goal is to best-in-class and position Singapore’s biologics manufacturing capabilities for the introduction of new products and cutting-edge production techniques.

Professor Lim Keng Hui, Assistant Chief Executive, Science and Engineering Research Council, A*STAR stated that new opportunities will arise as the biomanufacturing industry goes through significant changes brought on by the rapid pace of digitalisation, Industry 4.0, and the need for greater sustainability.

A*STAR seeks to contribute its R&D capabilities through BioPIPS to help the local biomanufacturing industry become more agile and better positioned to benefit from new products and technologies. Also, in its Research, Innovation, and Enterprise 2025 Plan, Singapore prioritises biopharmaceutical production.

BioPIPS expands on the consortium concept created by the Pharma Innovation Programme Singapore (PIPS), which was intended to strengthen Singapore’s capabilities in the production of small molecule pharmaceuticals consisting of chemical compounds.

Based on the success of PIPS, BioPIPS seeks to strengthen Singapore’s innovative capabilities in the production of biologics and vaccines by utilising the strengths of the top pharmaceutical firms and academic institutions.

The programme will create cutting-edge production technologies and solutions that are highly productive, sustainable, and innovative. Singapore is eager to expand collaborations with businesses that share its values to enhance its status as a centre to produce biopharmaceuticals worldwide.

BioPIPS will specifically feature three workstreams: First is the Sensing and Modelling Workstream intends to use smart sensors, mechanistic modelling, and machine learning to provide streamlined and quicker procedures. Data analytics will make it possible to effectively translate acquired process information into performance enhancements, which will benefit the manufacturing process.

Second is the Sustainability Workstream concentrates on addressing sustainability issues in the production of biologics and vaccines, which frequently require single-use (disposable) equipment because of the ultra-sterile conditions required for product purity. To address this challenge, this workstream will investigate the use of innovative materials, circular economy strategies, and models to encourage more resilient and sustainable supply chains.

And the third is the Compliant Agility Workstream which aims to increase productivity in manufacturing facilities while preserving compliance status by eliminating manual operations and utilising tools like robotics and cutting-edge analytics.

The Manufacturing 2030 vision of Singapore, which intends to anchor leading manufacturing operations to increase the nation’s manufacturing value-add by 50% from 2020, is consistent with BioPIPS.

The solutions created by BioPIPS will also improve Singapore’s capacity to meet the rising demand for biologics and vaccines around the world and give local pharmaceutical firms the tools they need to expand and react more quickly to pandemics in the future.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit www.planview.com.


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.

Send this to a friend